Cellular immunotherapy of cancer: an overview and future directions
6/1/2017 Immunotherapy. 2017 Jun;9(7):589-606 Tao Z, Li S, Ichim TE, Yang J, Riordan N, Yenugonda V, Babic I, Kesari S. The clinical success of checkpoint inhibitors has led to a renaissance of interest in cancer immunotherapies. In particular, the possibility of ex vivo expanding autologous lymphocytes that specifically recognize tumor cells has attracted much research…